Posts

Showing posts with the label agitation

nonpharmacologic therapy for aggression/agitation in dementia

  A recent systematic review/network meta-analysis of randomized controlled trials found that nonpharmacologic interventions were better than pharmacologic ones for reducing aggression and agitation in adults with dementia (see dementia nonpharm rx AIM2019 in dropbox, or doi:10.7326/M19-0993. Details: -- 163 studies were included in a network meta-analysis, including 23,143 people with dementia     -- mean patient age: 70-75yo in 10%/75-80yo in 29%/>80yo in 63%; most studies had at least 50% women     -- history of neuropsychiatric symptoms in 68%, not reported in 31%     -- type of dementia: 27% Alzheimer’s, 33% multiple (e.g. Alzheimer’s and vascular dementia), 37% not reported     -- dementia severity: mild-to-moderate 11%, mild-to-moderate-to-severe 27%, moderate-to-severe 20%, not reported 34%     -- study setting: community 18%, hospital 6%, nursing home/assisted-living 65% ...

citalopram improves Alzheimer's agitation

JAMA this week reported on the use of citalopram for agitation in people with Alzheimer's disease (see alzheimer agitation citalopram jama 2014 in dropbox, or doi:10.1001/jama.2014.93). details:     --double-blind study of 186 pts with probable alzheimer's and agitation (mean age 78, 46% women, 65% white, 70% on cholinesterase inhibitor and 42% on memantine) at 8 US and Canadian academic sites, all with 9 week psychosocial intervention, half with citalopram (began at 10mg, titrated up to 30mg over 3 weeks, and with 78% achieving the 30mg target). psychosocial intervention consisted of giving educational material, 24-hr availability for crisis management, and 20-30 minute counseling session at each visit, focusing on reviewing/adjusting supportive care plan, providing emotional support, counseling regarding specific caregiver skills, and assistance with problem solving on specific caregiver/patient issues.  At 9 weeks:     --18-point Neurobehaviora...